The New York Times – Business:
Millions of doses of Johnson & Johnson’s Covid-19 vaccine produced by Emergent BioSolutions have been held back in Europe, South Africa and Canada as a precaution.
Author: RSS Feed
This post first appeared in The New York Times – Business. Read the original article.